SEC Form 4 · accession 0001209191-15-004186
Foundation Medicine, Inc. · FMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven J. Kafka
Officer — Chief Operating Officer
Period of report
Jan 12, 2015
Accepted (ET)
Jan 14, 2015 · 4:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001488613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 12, 2015 | M | 8,000 | $7.12 | A | 12,680 | D | |
| Common StockF3 | Jan 12, 2015 | S | 8,000 | $51.8279 | D | 4,680 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $7.12 | Jan 12, 2015 | M | 8,000 | D | — | Mar 7, 2023 | Common Stock | 8,000 | 54,500 | D |
Explanation of responses
- F1The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2014.
- F2The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2014.
- F3The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.96 to $53.53, inclusive. The reporting person undertakes to provide Foundation Medicine, Inc., any security holder of Foundation Medicine, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
- F4This option was granted on May 22, 2013. 6.25% vests quarterly beginning August 22, 2013 until fully vested on May 22, 2017.